Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry
Main finding · Adjusted IDAA1CResult — go to the resultMean estimated difference 0.26 95% CI 0.17–0.35Study context
- Population
- Children and adolescents with newly diagnosed T1D, DPV registry
- Participants
- 7,603 children
- Exposure
- T1D onset during COVID-19 pandemic vs prepandemic
- Outcome
- Remission period measured by insulin-dose adjusted A1c (IDAA1C); remission prevalence (IDAA1c < 9%)
- Follow-up
- 3-5, 6-10 and 11-13 months after diagnosis
Methodological detailsprospective DPV registry, adjusted logistic and linear regression
- Prospective DPV registry
- Adjusted logistic and linear regression
Main finding
Adjusted IDAA1C · 3-5 months after diagnosis
Mean estimated difference
0.26
95% CI 0.17–0.35
P < 0.001
2020/2021 vs 2018/2019
mean estimated difference 0.26 (95% CI 0.17–0.35); P < 0.001
As reported in the abstract
Observational data: associations, not effects.
Further findings
| Outcome | Mean estimated difference (CI) | P value | |
|---|---|---|---|
| Adjusted IDAA1C · 6-10 months after diagnosis | 0.08 (−0.01 to 0.17) | P = 0.07 | |
| Adjusted IDAA1C · 11-13 months after diagnosis | −0.03 (−0.12 to 0.07) | P = 0.60 | |
| −0.2−0.100.10.2Difference (linear scale) |
Original publication
Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry. Pediatr Diabetes. Published 15 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →